EZH2 and acute myeloid leukemia: In the hematopoietic lineage, CRISPR/Cas9-mediated disruption of EZH2 significantly induced early AML, thereby providing further confirmation of the role of EZH2 in initiating AML (Tulkens et al., 2023).